Publication | Closed Access
Proteasome Inhibitor-Based Primary Therapy for Antibody-Mediated Renal Allograft Rejection
184
Citations
12
References
2010
Year
Proteasome inhibitor-based combination therapy provides a potential means for rapid DSA elimination in early acute AMR in renal transplant recipients.
| Year | Citations | |
|---|---|---|
Page 1
Page 1